Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
Clinical trial NCT06098079 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06098079
- Sponsor
- Currax Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2029-01-01
- Enrollment
- 8600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.